Try our Advanced Search for more refined results
November 30, 2023
Premera Blue Cross v. Takeda Pharmaceutical Company Limited et al
Case Number:
1:23-cv-12918
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 30, 2023
Premera Launches Fresh Takeda Antitrust Suit Over IBS Drug
A Blue Cross affiliate has once again lodged a proposed class action against Takeda Pharmaceuticals over an alleged conspiracy to keep generic versions of the drug Amitiza off the market, filing a tweaked version of its suit just weeks after a Massachusetts federal judge threw out its initial attempt.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login